Takeshi Hashimoto

8PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 14, 2025
Comparison of Oncological Outcomes of Conventional Androgen Deprivation Therapy (ADT) and ADT Plus Androgen Receptor Signaling Inhibitor in Older Patients With Metastatic Castration-Sensitive Prostate Cancer.

Yutaka Yamamoto, Saizo Fujimoto, Mamoru Hashimoto

|Jul 27, 2025
Prognostic Impact of Initial Prostate-Specific Antigen in Metastatic Hormone-Sensitive Prostate Cancer Patients With Extensive Bone Metastases Under Androgen Receptor Signaling Inhibitor.

Saizo Fujimoto, Tsuyoshi Morita, Yutaka Yamamoto

|Aug 23, 2024
Clinical outcomes and prognostic factors in metastatic nonclear cell renal cell carcinoma treated with immuno-oncology combination therapy.

Shingo Toyoda, Wataru Fukuokaya, Keiichiro Mori

|Mar 13, 2024
Significance of the cribriform morphology area ratio for biochemical recurrence in Gleason score 4 + 4 prostate cancer patients following robot-assisted radical prostatectomy.

Kenji Shimodaira, Rie Inoue, Takeshi Hashimoto

|Jun 06, 2020
Predicting factors for progression to castration resistance prostate cancer after biochemical recurrence in patients with clinically localized prostate cancer who underwent radical prostatectomy.

Takeshi Hashimoto, Jun Nakashima, Takeshi Kashima

|Nov 02, 2019
The significance of micro-lymphatic invasion and pathological Gleason score in prostate cancer patients with pathologically organ-confined disease and negative surgical margins after robot-assisted radical prostatectomy.

Takeshi Hashimoto, Jun Nakashima, Rie Inoue

Pageof 2

Frequent Collaborators

2 joint publications

Kiyoshi Takahara

2 joint publications

Yutaka Yamamoto

2 joint publications

Ryoichi Maenosono

2 joint publications

Wataru Fukuokaya